The influence of two megsin polymorphisms on the progression of IgA nephropathy.

The clinical course of chronic renal diseases and their progression to ESRD is highly variable. The strongest predictors of poor outcome of IgAN involve hypertension, severe proteinuria and elevated serum creatinine level. Different candidate gene polymorphisms have been advocated as possible modulators of the progression of IgAN. Megsin belongs to the serpin superfamily and was mapped to chromosome 18q21.3. Megsin plays a role in the regulation of a wide variety of processes in mesangial cells, such as matrix metabolism, cell proliferation, and apoptosis. Overexpression of Megsin might lead to mesangial dysfunction, and impair degradation of the mesangial matrix and disposal of immune complexes. The expression of Megsin is upregulated in a variety of glomerular diseases with mesangial injury in humans and in animal models. We investigated a possible association of two C2093T, C2180T polymorphisms of the megsin gene with the progression of IgAN towards ESRD, as well as the haplotype reconstruction of megsin gene polymorphisms and clinical manifestation of IgAN. We examined a group of 197 pts with histologically proven IGAN (84 pts with normal renal function, 113 pts with progressive renal insufficiency); as a control group we used 61 genetically unrelated healthy subjects. DNA samples from collected blood were genotyped for two singlenucleotide polymorphisms of megsin C2093T, C2180T by means of PCR with defined primers, electrophoresis on 2% agarose gel, UV light visualization and direct sequencing. The megsin genotype distribution showed no differences among the groups of IgAN with normal renal function, progressive renal insufficiency and the control group. According to haplotype analysis, the TT haplotype (defined as T-2093, T-2180 alleles) was substantially more frequent in pts with IgAN and normal renal function (Table 1, P = 0.025; Table 3, P = 0.062). Pts in the progressive group showed significantly higher levels of 24-h UP (3.53 +/- 2.80 vs 2.06 +/- 2.06, P = 0.042; Table 10), diastolic blood pressure (92.89 +/- 15.66 vs 84.93 +/- 10.43, P = 0.047; Table 10) and almost significantly systolic blood pressure (150.79 +/- 32.88 vs 135.21 +/- 14.88, P = 0.058; Table 10). We confirmed the negative prognostic influence of hypertension and proteinuria on the progression of IgAN in Czech pts. We found out that the TT haplotype (defined as T-2093, T-2180 alleles) could play a protective role in the progression of IgAN. In our Czech population, we excluded the negative influence of the 2093C-2180T haplotype, which was proposed by Chinese studies.

[1]  P. Maxwell,et al.  Association of MEGSIN 2093C-2180T haplotype at the 3' untranslated region with disease severity and progression of IgA nephropathy. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  Hui Guo,et al.  Family-based association study showing that immunoglobulin A nephropathy is associated with the polymorphisms 2093C and 2180T in the 3' untranslated region of the Megsin gene. , 2004, Journal of the American Society of Nephrology : JASN.

[3]  G. D'Amico,et al.  Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. , 2004, Seminars in nephrology.

[4]  E. Tan,et al.  Renin-Angiotensin System Gene Polymorphisms: Its Impact on IgAN and Its Progression to End-Stage Renal Failure among Chinese in Singapore , 2004, Nephron Physiology.

[5]  S. Goto,et al.  Peroxisome proliferator‐activated receptor γ C161T polymorphisms and survival of Japanese patients with immunoglobulin A nephropathy , 2003, Clinical genetics.

[6]  S. Goto,et al.  Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy. , 2003, Kidney international.

[7]  K. Akazawa,et al.  Interaction Between ACE and ADD1 Gene Polymorphisms in the Progression of IgA Nephropathy in Japanese Patients , 2003, Hypertension.

[8]  M. Nangaku,et al.  Mesangial cell-predominant functional gene, megsin , 2003, Journal of Clinical and Experimental Nephrology.

[9]  M. Nangaku,et al.  Transcriptional regulation of a mesangium-predominant gene, megsin. , 2002, Journal of the American Society of Nephrology : JASN.

[10]  K. Akazawa,et al.  A(-20)C polymorphism of the angiotensinogen gene and progression of IgA nephropathy. , 2002, Kidney international.

[11]  P. Finne,et al.  Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease. , 2002, Clinical nephrology.

[12]  E. Bergstralh,et al.  Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  S. Goto,et al.  Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients. , 2002, Kidney international.

[14]  D. Cattran,et al.  Predicting progression in IgA nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  M. Nangaku,et al.  Specific tissue distribution of megsin, a novel serpin, in the glomerulus and its up-regulation in IgA nephropathy. , 2001, Biochemical and biophysical research communications.

[16]  J. S. Lee,et al.  Uteroglobin gene polymorphisms affect the progression of immunoglobulin A nephropathy by modulating the level of uteroglobin expression. , 2001, Pharmacogenetics.

[17]  T. Lehtimäki,et al.  Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Prognosis of IgA Nephropathy , 2000, Nephron.

[18]  A. Busjahn,et al.  Association of a uteroglobin polymorphism with rate of progression in patients with IgA nephropathy. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  W. Owen,et al.  Evidence for genetic factors in the development and progression of IgA nephropathy. , 2000, Kidney international.

[20]  M. Nangaku,et al.  Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases. , 1999, Journal of the American Society of Nephrology : JASN.

[21]  William Arbuthnot Sir Lane,et al.  Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. , 1999, Science.

[22]  M. Nangaku,et al.  A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathy. , 1998, The Journal of clinical investigation.

[23]  Y. Hiki,et al.  Prognostic prediction of long‐term clinical courses in individual IgA nephropathy patients , 1997 .

[24]  M. Baker,et al.  Biological and clinical aspects of plasminogen activator inhibitor type 2. , 1995, Blood.

[25]  F. Bachmann,et al.  The Enigma PAI-2. Gene Expression, Evolutionary and Functional Aspects , 1995, Thrombosis and Haemostasis.

[26]  W. Couser,et al.  Role of oxidants and proteases in glomerular injury. , 1994, Kidney international.

[27]  D. Lovett,et al.  Proteinases and glomerular matrix turnover. , 1992, Kidney international.

[28]  J. Mustonen,et al.  Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  Y. Berland,et al.  Tubular lesions determine prognosis of IgA nephropathy. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  P. Bird Serpins and regulation of cell death. , 1998, Results and problems in cell differentiation.

[31]  R. D. McCoy,et al.  Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. , 1996, Journal of Clinical Investigation.